Prime Medicine, Inc. (PRME) Total liabilities 2021–2025
Prime Medicine, Inc. (PRME) total liabilities at each fiscal year-end, per SEC filings.
$221.9MFY2025 · since FY2021: $62.3M → $221.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $221.9M | +53.7% |
| FY2024 | $144.4M | +137.5% |
| FY2023 | $60.8M | +38.0% |
| FY2022 | $44.0M | -29.3% |
| FY2021 | $62.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PRME financial trends
PRME RevenuePRME Net incomePRME Net marginPRME Gross profitPRME Gross marginPRME Operating incomePRME Operating marginPRME Operating cash flowPRME Free cash flowPRME Capital expendituresPRME Return on equityPRME Stock buybacksPRME Dividends paidPRME Total assetsPRME Shareholders’ equityPRME overview →